Effective siRNAs inhibit the replication of novel influenza A (H1N1) virus

Antiviral Res. 2010 Mar;85(3):559-61. doi: 10.1016/j.antiviral.2009.12.010. Epub 2010 Jan 7.

Abstract

In March and April 2009, an entirely novel influenza A (H1N1) virus (NIAV) emerged in Mexico and the USA. During the subsequent months, the virus rapidly spread all over the world by person-to-person transmission. In this report, RNA interference (RNAi) was used as an antiviral agent to inhibit NIAV replication in A549 cells. Ten small interfering RNAs (siRNAs) targeting extremely conserved regions among multiple NIAV genomes could effectively block the replication of NIAV strain A/Beijing/01/2009 (H1N1) in A549 cells. This study may be useful to confront the sudden emergence of NIAV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology*
  • Cell Line
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • RNA, Small Interfering / pharmacology*
  • Virus Replication / drug effects*

Substances

  • Antiviral Agents
  • RNA, Small Interfering